Literature DB >> 9721181

Role of the 3'-untranslated region of RPE65 mRNA in the translational regulation of the RPE65 gene: identification of a specific translation inhibitory element.

S Y Liu1, T M Redmond.   

Abstract

Previously, we demonstrated that explanted bovine retinal pigment epithelium (RPE) cells lose RPE65 protein, a major microsomal protein specific to RPE, while the RPE65 mRNA remains, suggesting posttranscriptional regulation of RPE65 expression in vitro. Accordingly, we analyze here the effect of the 5'- and 3'-untranslated regions (UTRs) of RPE65 mRNA on translational efficiency using in vitro translation systems. We compared the levels of translation products and mRNA stability among RPE65 transcripts containing deletions of the 5'- and 3'-UTRs. First, the 5'-UTR does not affect translational efficiency. However, the 3'-UTR does influence translation efficiency. A putative translation inhibitory element (TIE) is contained within the 170-nucleotide (nt) sequence downstream of the stop codon. There is also a weak destabilizing effect that is associated with the region 3' to the putative TIE. But the effect of this is much less than that of the TIE. This TIE, however, does not inhibit translation of the heterologous chloramphenicol acetyltransferase gene, suggesting that a specific interaction with the upstream RPE65 coding sequence, or its product, may be required. Thus, the posttranscriptional regulation of RPE65 mRNA expression observed in cultured RPE may be via a mechanism of translational inhibition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721181     DOI: 10.1006/abbi.1998.0817

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium.

Authors:  A D Marmorstein; L Y Marmorstein; M Rayborn; X Wang; J G Hollyfield; K Petrukhin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Regulatory sequences in the 3' untranslated region of the human cGMP-phosphodiesterase beta-subunit gene.

Authors:  Mark R Verardo; Andrea Viczian; Natik Piri; Novrouz B Akhmedov; Barry E Knox; Debora B Farber
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-14       Impact factor: 4.799

Review 3.  Key enzymes of the retinoid (visual) cycle in vertebrate retina.

Authors:  Philip D Kiser; Marcin Golczak; Akiko Maeda; Krzysztof Palczewski
Journal:  Biochim Biophys Acta       Date:  2011-04-05

4.  Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation.

Authors:  K M Ropponen; J K Kellokoski; R T Pirinen; K I Moisio; M J Eskelinen; E M Alhava; V M Kosma
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

Review 5.  Stem cell-based therapeutic applications in retinal degenerative diseases.

Authors:  Yiming Huang; Volker Enzmann; Suzanne T Ildstad
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

6.  Analysis of retinal pigment epithelium integrin expression and adhesion to aged submacular human Bruch's membrane.

Authors:  Marco A Zarbin
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 7.  An analysis of retinal gene therapy clinical trials.

Authors:  Robert E MacLaren
Journal:  Curr Opin Mol Ther       Date:  2009-10

8.  Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma.

Authors:  J M Karjalainen; J K Kellokoski; A J Mannermaa; H E Kujala; K I Moisio; P J Mitchell; M J Eskelinen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

9.  Lentiviral mediated RPE65 gene transfer in healthy hiPSCs-derived retinal pigment epithelial cells markedly increased RPE65 mRNA, but modestly protein level.

Authors:  Florian Udry; Sarah Decembrini; David M Gamm; Nicole Déglon; Corinne Kostic; Yvan Arsenijevic
Journal:  Sci Rep       Date:  2020-06-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.